A double blind trial of a new topical steroid formulation containing desoximetasone against fluocinolonacetonid cream
- PMID: 132779
A double blind trial of a new topical steroid formulation containing desoximetasone against fluocinolonacetonid cream
Abstract
A randomized double-blind left-right comparative trial was carried out between a new steroid Desoximetason 0,25% (Ibaril) and fluocinolone acetonide 0,025% cream. Evaluation of symptoms on 50 patients suffering from endogenous eczema was recorded after 1, 2, 3 and 4 weeks. There was a significantly better effect of Ibaril compared to Fluocinolone-acetonide as judged by the observer during the 1st, 3rd and 4th week of treatment. After the 2nd week treatment Ibaril showed a better effect, however, a significancy could not be established.